Mario Enrico Canonico/LinkedIn
Aug 20, 2026, 13:46
Mario Enrico Canonico։ CLEAR Outcomes Analysis Highlights Bempedoic Acid Benefits in PAD
Mario Enrico Canonico, Assistant Research Professor of Medicine at University of Colorado, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Circulation, adding:
”Excited to share our analysis from the CLEAR Outcomes trial, led by Marc Bonaca, now published in Circulation!
Bempedoic acid reduced MACE and MALE in patients with PAD.”
Title: Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial
Authors: Marc P. Bonaca, Mario Enrico Canonico, Na Li, William J. Sasiela, Steven E. Nissen, A. Michael Lincoff, Stephen J. Nicholls
Stay updated on the latest scientific advances with Hemostasis Today.
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target
-
Oct 7, 2026, 15:28Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
-
Oct 7, 2026, 15:21Eloïse Laouenan: Bridging Immunity and Thrombosis in MVTE
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story
-
Oct 7, 2026, 14:49Aimee Burtenshaw: The Impact of the Infected Blood Inquiry on Hospital Transfusion Laboratories
-
Oct 7, 2026, 14:41Vikash Jaiswal: Does Timing Matter for Calcium in Pre-Eclampsia Prevention?